Skip to main content
. Author manuscript; available in PMC: 2011 Dec 20.
Published in final edited form as: Proteomics Clin Appl. 2010 Jan 4;4(3):295–303. doi: 10.1002/prca.200900083

Table 4.

Correlations between Markers & Brain Status at 3 Yr Follow-Up

Marker NBPV WM GM CSF MD FA
Eotaxin -.14 -.66* -.10 .29 .37 -.55
GM-CSF .26 -.62(*) .24 -.07 -.13 -.40
IFNγ .42 -.42 .42 -.32 -.32 -.17
IL-10 --- --- --- --- --- ---
IL-12p40 .28 -.04 .00 -.12 -.28 -.08
IL-12P70 --- --- --- --- --- ---
IL-13 --- --- --- --- --- ---
IL-15 .34 -.47 .44 -.20 -.31 -.26
IL-1α
IL-1β --- --- --- --- --- ---
IL-2 .41 -.51 .46 -.26 -.24 -.29
IL-3 .23 -.20 .02 -.08 -.08 -.30
IL-4 .36 -.60(*) .46 -.26 -.20 -.34
IL-5 --- --- --- --- --- ---
IL-6
IL-7 .83* -.15 .48 -.64 -.51 .12
IL-8 .24 -.37 .07 .02 -.17 -.31
IP-10 .05 -.20 -.01 .09 -.17 -.03
MCP-1 -.64* -.24 -.83** .77** .66* -.63*
MIP-1α .52 -.36 .40 -.36 -.36 -.17
RANTES -.36 -.44 -.06 .32 .24 -.44
TNFα .09 -.42 .25 -.06 -.08 -.40

Abbreviations: NBPV:normalized parenchymal brain volume, WM: white matter, GM: gray matter, CSF: cerebrospinal fluid, MD: mean diffusivity, FA: fractional anisotropy.

Beyond limits of detection (low) in at least half of the subjects.

---

Beyond limits of assay detection (uniformly low) in all subjects.

*

p <.05;

**

p.01;

(*)

p<.10